Back to Daily DR Market Summary

StreetAccount Summary - Asian Market Preview: Nikkei Futures +0.37%, Hang Seng Futures 0.00%, ASX SPI 200 +0.24%, S&P Futures (0.06%)

Oct 13 ,2024

  • Synopsis:

    • Asian markets set for positive start to Monday trade. ASX opens with mild gains as Hong Kong resumes following Friday holiday. Japan closed for Heath-Sports day holiday. S&P 500 futures flat after US indexes notched fifth straight weekly gain. Australia and New Zealand bonds under pressure as Treasury curve continues to steepen. Yen nearing lowest against dollar since early August. Crude and base metals markets weakening in China press conference aftermath. Bitcoin remains range bound.

    • At Saturday press conference, China's finance minister flagged targeted fiscal policy measures to support growth. Package includes raising debt ceiling, tapping unused funding from special purpose bonds, and measures to stabilize property market. Press takeaways noted absence of headline figure after sell-side previews predicted package of up to CNY2.0T. Also lacked new policies to boost consumption.

    • China pricing pressures dissipated in September with CPI inflation unexpectedly softening. Figure propped up by volatile food prices with core inflation flatlining to lowest since Feb-2021. PPI deflation also worsened by more than expected. Data underscored continued weakness in domestic demand before authorities unveiled flurry of stimulus announcements in mid-September.

  • Pre-open Company News:

    • 541153.IN -- Quick Take - Bandhan Bank trades +10.6% vs (0.7%) for Nifty Bank; street notes removal of overhang

    • Sealand Securities initiates 1698.HK, 9899.HK

    • 1361.HK -- 361 Degrees International initiated buy at Huatai Securities

    • 541770.IN -- Quick Take - CreditAccess Grameen trades (4.0%) vs (0.2%) for Nifty 50

    • 507685.IN -- At its 17-Oct meeting, Wipro board to consider proposal for issue of bonus shares

    • 600276.CH -- Jiangsu Hengrui Pharmaceuticals announces acceptance of its drug marketing authorization application for SHR2554 tablets

    • 3349.JP -- COSMOS Pharmaceutical upgraded to neutral from underperform at Macquarie

    • 2887.TT -- Taishin Financial Holdings downgraded to neutral from buy at Cathay Financial

    • SCC.TB -- The Siam Cement Public downgraded to neutral from buy at RHB Research

    • SCC.TB -- The Siam Cement Public downgraded to hold from buy at DBS Group

    • 4480.JP -- Medley initiated buy at SBI Securities Japan

    • 6855.HK -- Ascentage Pharma initiated outperform at Haitong

    • China inflation data softer than expected:

    • 500408.IN -- Street Takeaways - Tata Elxsi Q2 Earnings

    • 600021.CH -- Shanghai Electric Power guides 9M net income attributable CNY2.252-2.680B, +53.30%-82.44% y/y

  • On Deck:

    • China:

      • Economic:

        • 08:00 CST: Loan Growth Y/Y; consensus

        • 08:00 CST: M2 NSA Y/Y; consensus +6.4%

        • 08:00 CST: New Yuan Loans; consensus

        • 08:00 CST: Export Y/Y; consensus +6%

        • 08:00 CST: Import Y/Y; consensus +2%

        • 08:00 CST: Trade Balance NSA; consensus +$88.5B

    • New Zealand:

      • Earnings:

        • Manawa Energy (MNW.NZ)

    • India:

      • Earnings:

        • Reliance Industries (500325.IN), Angel One (543235.IN), Sterling & Wilson Renewable Energy (542760.IN)

    • Singapore:

      • Economic:

        • 08:00 SST: GDP NSA Y/Y (Preliminary); consensus +3.3%

  • Market Data:

    • Gold (Dec 24): ($9.90) or (0.37%) to $2666.40

    • WTI Crude (Nov 24): ($1.30) or (1.72%) to $74.26

    • $-¥: +0.16 or +0.11% to 149.3020

    • $-KRW: (1.00) or (0.07%) to 1348.3200

    • A$-$: (0.00) or (0.39%) to 0.6724

    • $-INR: +0.04 or +0.05% to 84.1371

    • $-CNY: (0.00) or (0.01%) to 7.0652

  • If you would like to receive the Asian Market Preview daily, please search for Asia Pre-Market Updates in Alert Manager.

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE